Creative Medical Technology Holdings, Inc. (CELZ) Financials

$2.48

north_east
$0.04 (1.64%)
Day's range
$2.43
Day's range
$2.55

CELZ Income statement / Annual

Last year (2023), Creative Medical Technology Holdings, Inc.'s total revenue was $9,000.00, a decrease of 89.84% from the previous year. In 2023, Creative Medical Technology Holdings, Inc.'s net income was -$5.29 M. See Creative Medical Technology Holdings, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $9,000.00 $88,600.00 $87,754.00 $164,500.00 $165,500.00 $124,400.00 $4,800.00 $0.00 $0.00 $0.00
Cost of Revenue $3,600.00 $28,491.00 $47,949.00 $50,596.00 $45,499.00 $70,375.00 $8,000.00 $766,072.00 $0.00 $0.00
Gross Profit $5,400.00 $60,109.00 $39,805.00 $113,904.00 $120,001.00 $54,025.00 -$3,200.00 -$766,072.00 $0.00 $0.00
Gross Profit Ratio 0.6 0.68 0.45 0.69 0.73 0.43 -0.67 0 0 0
Research and Development Expenses $1.97 M $6.27 M $109,180.00 $0.00 $0.00 $96,621.00 $260,085.00 $85,334.00 $0.00 $0.00
General & Administrative Expenses $0.00 $0.00 $0.00 $0.00 $1.22 M $1.05 M $898,526.00 $664,984.00 $20,831.00 $19,426.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $3.56 M $3.94 M $2.96 M $1.16 M $1.22 M $1.05 M $898,526.00 $664,984.00 $20,831.00 $19,426.00
Other Expenses $94,584.00 $92,084.00 $92,084.00 $66,792.00 $26,950.00 $21,144.00 $0.00 $9,356.00 $0.00 $0.00
Operating Expenses $5.63 M $10.30 M $3.17 M $1.23 M $1.25 M $1.17 M $1.17 M $759,674.00 $20,831.00 $19,426.00
Cost And Expenses $5.63 M $10.33 M $3.21 M $1.28 M $1.30 M $1.24 M $1.18 M $759,674.00 $20,831.00 $19,426.00
Interest Income $333,558.00 $100,328.00 $4.28 M $1.23 M $1.90 M $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $4.28 M $1.23 M $1.90 M $1.36 M $377,587.00 $6,398.00 $9,930.00 $8,586.00
Depreciation & Amortization $94,584.00 $92,084.00 $92,084.00 $66,792.00 $26,950.00 $21,144.00 $15,994.00 $9,356.00 $0.00 $0.00
EBITDA -$5.53 M -$10.15 M -$3.03 M -$1.05 M -$1.10 M -$1.09 M -$1.16 M -$750,318.00 -$20,831.00 -$19,426.00
EBITDA Ratio -613.95 -113.45 -34.57 -6.37 -6.67 -8.79 -242.04 0 0 0
Operating Income Ratio -624.46 -115.62 -35.62 -6.78 -6.83 -8.96 -245.38 0 0 0
Total Other Income/Expenses Net $333,558.00 $100,328.00 $22.34 M -$35.21 M -$7.35 M -$12.54 M -$1.48 M -$6,398.00 -$9,930.00 -$8,586.00
Income Before Tax -$5.29 M -$10.14 M $19.21 M -$36.33 M -$8.48 M -$13.66 M -$2.66 M -$766,072.00 -$30,761.00 -$28,012.00
Income Before Tax Ratio -587.4 -114.49 218.93 -220.82 -51.26 -109.77 -553.98 0 0 0
Income Tax Expense $0.00 -$100,328.00 $4.28 M $1.23 M $1.90 M -$11.18 M $377,587.00 $12,796.00 $0.00 $0.00
Net Income -$5.29 M -$10.04 M $14.93 M -$37.55 M -$10.38 M -$13.66 M -$2.66 M -$766,072.00 -$30,761.00 -$28,012.00
Net Income Ratio -587.4 -113.36 170.17 -228.3 -62.71 -109.77 -553.98 0 0 0
EPS -3.76 -9.19 57.32 -648.1 -5017.67 -11351.33 -17379.79 -5471.94 -1281.71 -1167.17
EPS Diluted -3.76 -9.19 45.97 -648.1 -5017.67 -11351.33 -17379.79 -5471.94 -1281.71 -1167.17
Weighted Average Shares Out $1.41 M $1.09 M $260,505.00 $57,946.00 $2,068.53 $1,203.00 $153.00 $140.00 $24.00 $24.00
Weighted Average Shares Out Diluted $1.41 M $1.09 M $324,861.00 $57,946.00 $2,068.53 $1,203.00 $153.00 $140.00 $24.00 $24.00
Link